Kisspeptin-10 Peptide Research: Insights into Reproduction

In humans, Kisspeptin-10 is a powerful endogenous ligand that binds to the Kisspeptin receptor (also known as KISS1 or GPR54). It has a high affinity for binding to the KISS1 receptors of both rats and humans, with Ki values of 1.59 and 2.33 nM per receptor, respectively. In mouse melanomas, it causes an inhibition of metastasis and invasion, and it causes a stimulation of gonadotropin secretion after intravenous injection.

In humans, Kisspeptin is a protein that occurs naturally and plays a significant role in the transmission of hormones throughout puberty and reproduction.  In addition to these effects, it is believed to influence both behavior and mood, to stimulate angiogenesis, and to control renal function.  A protein called kisspeptin has also been discovered in the brain, and it is known to inhibit the growth and spread of tumors.  Because of its capacity to alter gonadotropin-releasing hormone (GnRH), it is also well-known and has been the subject of extensive research.

 In the hypothalamus of the brain, specific nerve cells are responsible for the production and secretion of the hormone that releases gonadotropin by the body.  This hormone is transported from the brain to the pituitary gland, where it stimulates the synthesis of two more hormones: follicle-stimulating hormone and luteinizing hormone. It is released into the tiny blood channels that carry this hormone from the brain to the pituitary gland.  Following their release into the general circulation, these hormones exert their influence on the testes and ovaries, causing them to commence and continue to perform their reproductive duties.

Mechanism of Action of Kisspeptin-10 Peptide

Kisspeptins are essential regulators of the reproductive physiology of mammalian organisms.  When it comes to humans, pubertal failure is caused by inactivating mutations of the kisspeptin receptor (KISS1R), while activating mutations might lead to premature puberty.  The human kisspeptin peptides, which are designated as kisspeptin-10, -13, -14, and -54, are given their names based on the number of amino acids that they contain together.  It is necessary for kisspeptin-10, which is the C-terminal decapeptide sequence, to be present in all kisspeptin peptides for them to exhibit biological activity in vitro.

It has been proven that the administration of the shorter kisspeptin peptide, known as kisspeptin-10, either centrally or peripherally can promote the release of gonadotropin in a number of different mammalian species.  When an antagonist to the hypothalamic hormone GnRH is administered prior to the injection of the hormone, this effect is eliminated. 

It is consequently believed that kisspeptin-10 stimulates the release of gonadotropin from the pituitary gland, which in turn stimulates the release of GnRH from the hypothalamus. 

Additionally, it has been demonstrated that the longer kisspeptin peptide, known as kisspeptin-54, can trigger the production of gonadotropin in rodents.  Furthermore, the injection of kisspeptin-54 has been shown to enhance the production of gonadotropin in human beings.  Because of this, kisspeptin has the potential to become an innovative medication for the treatment of reproductive diseases in human beings.

Since kisspeptin-10 has a shorter sequence of amino acids than kisspeptin-54, its synthesis is less complicated and more cost-effective by comparison. 

Therefore, it is possible that future kisspeptin therapies will be based on kisspeptin-10 rather than Kisspeptin-54.  In order to determine whether or whether Kisspeptin-10 can increase the release of reproductive hormones in healthy men and women, it is therefore medically vital to accomplish this testing. 

When administered to male rhesus monkeys, Kisspeptin-10 promotes the release of gonadotropin. In addition, two investigations that were published not too long ago suggested that the administration of kisspeptin-10 to healthy men promotes the release of growth hormone. 

Despite the fact that Kisspeptin-10 is known to stimulate the release of gonadotropin in animals, there is no published research that investigates the effects of providing Kisspeptin-10 to female primates or humans.

Kisspeptin-10 Peptide Research Evidence

In order to stimulate the release of gonadotropin-releasing hormone, Kisspeptin-10 first binds to the Kisspeptin cognate receptor and then stimulates it. This is how it achieves its function as a gonadotropin-releasing hormone stimulator. 

After that, the stimulation causes the release of gonadotropin, which is thought to be responsible for producing the desired effects.  Exogenous injection of this neuropeptide, which is naturally released by the hypothalamus, is commonly regarded as a significant factor in the regulation of GnRH, according to the findings of scientists. 

The evidence that highlights the consequences of mutations in the KISS1 gene reveals that this g protein-coupled receptor plays a crucial role in either early or delayed pubertal growth.

In addition, Kisspeptin neurons have the capacity to induce dynamic LH production and result in an increase in LH levels in both males and females. 

Since this is the case, it is possible to assert that Kisspeptin-10 is also an LH secretagogue.  KP-10 is the most powerful form of human Kisspeptin, despite the fact that there are multiple isoforms of Kisspeptin. This is because it has a shorter half-life and has its effects more quickly after being administered intravenously. 

Several investigations conducted on adult male rats came to the same conclusion: Kisspeptin signaling, which is mediated by the hypothalamic-pituitary-gonadal axis (HPG axis), has the ability to drive sexual and emotional brain processing (by affecting the pituitary cells) in relation to olfaction, fear, anxiety, and sexual arousal. 

In addition, research indicates that Kisspeptin-10 may be able to establish a connection between nutritional condition and fertility.  Additionally, the effect of Kisspeptin-10 has the potential to boost testosterone secretion levels in men, as well as an increase in sex-related motivation and cardiovascular function.  Because of its capacity to promote the secretion of serum LH, it has been a major area in research that investigates potential new treatments for infertility and other reproductive health disorders.

Through a possible manipulation of the levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) that are circulating in the body, Kisspeptin-10 peptide has the potential to affect the levels of testosterone. 

On the other hand, it seems that the effect of Kisspeptin peptide on testosterone is one that is gender-specific.  Peptide introduction appeared to induce a rise in testosterone levels in male test models, however, in female test models, it did not appear to generate any apparent effect on testosterone. This variation was observed in both male and female test models. 

Particularly noteworthy is the fact that clinical research that involved six male patients and had them receiving a derivative of Kisspeptin-10 appeared to reveal a considerable spike in plasma testosterone levels, virtually tripling after only ninety minutes.

In addition, Kisspeptin-10 infusion peptide appears to have an effect on the pulsatile release of LH in male test subjects, which suggests that it may play a function in the regulation of the normal rhythmic release of sex hormones. 

A quick and concentration-dependent spike in blood LH levels was seen in another investigation involving healthy male individuals who were given Kisspeptin-10. This elevation was accompanied by a concomitant increase in testosterone levels over the course of the trial. 

According to the findings of certain studies, IV infusion of Kisspeptin-10 could be able to accomplish this effect by contributing to an increase in the pulsatile release of LH. 

Kisspeptin-10 peptide appears to generate such rapid pulsing at higher concentrations that individual pulses become indistinguishable, which results in the continuous release of luteinizing hormone (LH).  "Kisspeptin-10 boluses potently evoke LH secretion [...]," the researchers claimed, "and continuous infusion increases testosterone, LH pulse frequency, and pulse size." Kisspeptin-10 boluses are administered in a continuous manner.  As regulators of LH and, consequently, testosterone release, Kisspeptin analogs have the potential to be used in therapeutic applications.

Research Applications

Kisspeptin and Cancer: Biological Roles, Molecular Interaction, and Prospects for the Future

One of the primary areas of medical research is cancer sickness, which is the second greatest cause of death worldwide. 

The basic principles underlying unchecked cell proliferation, invasiveness, and metastasis are now better recognized, but the multi-step process of cancer formation and evolution remains poorly understood. 

One of the hottest topics in cancer research is the suppression of molecules involved in cancer metastasis. Metastasis suppressor gene kiss-1 encodes.

The anticancer effect of KiSS-1 was chiefly linked to the suppression of proliferation, migration, and cellular invasion, resulting in less metastasis and reduced development of intratumoral microvessels.  This review emphasizes recent findings about the function of Kisspeptin signaling in inhibiting metastasis across different cancer types and the potential application of KiSS/GPR54 signaling modulators as innovative therapeutic agents for cancer treatment.

Energy balance and Kisspeptin in reproduction

The neuroendocrine control of GNRH secretion depends on Kisspeptin.  It is now known that a major pathway that transmits important homeostatic information to GNRH neurons is Kisspeptin neurons. 

The known relationship between energy balance and reproductive function is probably mediated by this route.  

It's interesting to note that Kisspeptin neurons are anatomically associated with anorexigenic POMC neurons and have the ability to directly excite them while indirectly inhibiting orexigenic NPY neurons. 

Kisspeptin may therefore play a direct part in controlling energy balance. Despite the lack of variations in body weight between Kiss1r knockout and WT mice, new research suggests that Kisspeptin may still be involved in glucose homeostasis and food intake.  Kisspeptin signaling may therefore be a direct regulator of metabolism in addition to controlling reproduction and moderating the impact of energy balance on reproductive function.

Kisspeptin neurons' function in metabolism and reproduction

A neuropeptide called Kisspeptin is essential to the hypothalamic-pituitary-gonadal (HPG) axis's operation. 

The arcuate nucleus (ARC) and the rostral periventricular region of the third ventricle (RP3V) are the two main neuronal populations in the hypothalamus that produce Kisspeptin. 

By projecting to and activating gonadotrophin-releasing hormone (GnRH) neurons in the hypothalamus, these neurons induce the release of GnRH through the Kisspeptin receptor, Kiss1r. 

It is now widely believed that the ARC Kisspeptin neurons function as the GnRH pulse generator. Gonadal sex hormones excite Kisspeptin neurons in the RP3V but inhibit those in the ARC, which is the underlying mechanism for positive and negative feedback, respectively.  Afferent inputs to Kisspeptin neurons have been the subject of recent research due to Kisspeptin's profound effect on the HPG axis.  

Current research is examining how injection of Kisspeptin-10 signaling affects behavior and how Kisspeptin-10 increases LH secretion in men. Since there is clinical evidence that dose of Kisspeptin-10 influences sexual behavior, more research into possible neural connections is necessary.

Future Research Perspectives

Kisspeptin-10, a neuropeptide, is posited to modulate reproduction and energy homeostasis. It seemingly operates via the GPR54 receptor and may stimulate GnRH release, thereby affecting gonadotropin hormones. Research suggests Kisspeptin-10 administration has potential involvement in regulating vascular development, angiogenesis, and mitigating tumor metastasis. Recent studies have correlated Kisspeptin levels with daylight exposure and tumor proliferation rates. Additional research is necessary to comprehensively clarify its mechanisms and assess its applications.

References

1. Jayasena CN, Nijher GM, Comninos AN, Abbara A, Januszewki A, Vaal ML, Sriskandarajah L, Murphy KG, Farzad Z, Ghatei MA, Bloom SR, Dhillo WS. The effects of Kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab. 2011 Dec;96(12):E1963-72. doi: 10.1210/jc.2011-1408. Epub 2011 Oct 5. PMID: 21976724; PMCID: PMC3232613.

2. Messager, S., Chatzidaki, E. E., Ma, D., Hendrick, A. G., Zahn, D., Dixon, J., Thresher, R. R., Malinge, I., Lomet, D., Carlton, M. B., Colledge, W. H., Caraty, A., & Aparicio, S. A. (2005). Kisspeptin-10 directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proceedings of the National Academy of Sciences of the United States of America, 102(5), 1761–1766.  

3. Rønnekleiv, O. K., & Kelly, M. J. (2013). Kisspeptin-10 excitation of GnRH neurons. Advances in experimental medicine and biology, 784, 113–131.  

4. Tng E. L. (2015). Kisspeptin-10 signaling and its roles in humans. Singapore Medical Journal, 56(12), 649–656.  

5. Pasquier, J., Kamech, N., Lafont, A., Vaudry, H., Rousseau, K., & Dufour, S. (2014). MOLECULAR EVOLUTION OF GPCRS: Kisspeptin-10/Kisspeptin-10 receptors, Journal of Molecular Endocrinology, 52(3), T101-T117.